C.M. Bidwell & Associates’s Cantel Medical Corporation CMD Stock Holding History

C.M. Bidwell & Associates’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-465	Closed	-$37K	–	641
2021 Q1	$37K	Sell	465 -25	-5%	-$1.95K	0.03%	323
2020 Q4	$39K	Buy	+490	New	+$28.7K	0.03%	302

C.M. Bidwell & Associates's CMD Position: Q2 2021 in Review

C.M. Bidwell & Associates sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 465 shares — an estimated $37K sold.

C.M. Bidwell & Associates first reported a position in CMD in Q4 2020 and held it in 2 quarters. The position peaked at $39K in Q4 2020. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.

C.M. Bidwell & Associates reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
C.M. Bidwell & Associates sold 465 Cantel Medical Corporation shares in Q2 2021, an estimated $37K.
C.M. Bidwell & Associates first reported a position in Cantel Medical Corporation in Q4 2020 and held it in 2 quarters.
C.M. Bidwell & Associates's Cantel Medical Corporation position peaked at $39K in Q4 2020.
0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.

Based on C.M. Bidwell & Associates's 13F filing for Q2 2021, filed 13 Aug 2021.